Subjects |
23 |
12 |
11 |
患者特征 |
|
|
|
Age years |
46.5±9.0 |
47.0±9.3 |
45.7±8.9 |
Duration of disease year |
13.5±9.1 |
14.5±9.0 |
12.5±9.4 |
Post-menopause |
8 |
4 |
4 |
Pneumothorax# |
18 |
9 |
9 |
Angiomyolipoma¶ |
14 |
6 |
8 |
TSC-LAM |
1 |
0 |
1 |
Supplemental oxygen use |
5 |
3 |
2 |
Lung function % predicted |
|
|
|
FEV1 |
58±23 |
52±25 |
64±19 |
FVC |
95±22 |
97±26 |
92±18 |
TLCO |
51±21 |
45±21 |
57±20 |
TLC |
94±20 |
99±23 |
89±15 |
Other parameters |
|
|
|
Shuttle walk distance m |
573±286 |
560±284 |
586±301 |
SGRQ总分 |
35±4 |
36±6 |
33±6 |
VEGF-D pg·mL−1 |
2540±1377 |
2347±1399 |
2751±1387 |